Rolaids Extra Strength Fruit Tablet, Chewable
NDC Package 41167-1002-2
Package Information
Rolaids Extra Strength Fruit (calcium carbonate and magnesium hydroxide) tablets is chew 2-4 tablets as symptoms occur, or as directed by a doctor chew 2-4 tablets as symptoms occur, or as directed by a doctor chew 2-4 tablets as symptoms occur, or as directed by a doctor . This formulation utilizes a tablet, chewable delivery system. Marketed by Chattem, Inc., this product is identified by NDC 41167-1002 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 476549 - calcium carbonate 675 MG (Ca 270 MG) / magnesium hydroxide 135 MG Chewable Tablet
- RxCUI: 476549 - calcium carbonate 675 MG / magnesium hydroxide 135 MG Chewable Tablet
- RxCUI: 476549 - calcium carbonate 675 MG / milk of magnesia 135 MG Chewable Tablet
- RxCUI: 642355 - Rolaids EXTRA Strength 675 MG (Ca 270 MG) / 135 MG (Mg 55 MG) Chewable Tablet, Reformulated Aug 2006
- RxCUI: 642355 - calcium carbonate 675 MG / magnesium hydroxide 135 MG Chewable Tablet [Rolaids Reformulated Aug 2006]
Clinical Specifications
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 41167 - Chattem, Inc.
- 41167-1002 - Rolaids Extra Strength Fruit
- 41167-1002-2 - 116 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
- 41167-1002 - Rolaids Extra Strength Fruit
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (41167-1002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 41167-1002-2 identifies a specific commercial package of 116 tablet, chewable in 1 bottle, plastic of Rolaids Extra Strength Fruit, a human over the counter drug labeled by Chattem, Inc.. This tablet, chewable is formulated for oral use and contains calcium carbonate; magnesium hydroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chattem, Inc. on September 01, 2013. The current certification is valid through December 31, 2027.
How is this Chattem, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 41167100202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.